Cancer · 1992 · 44 citations · 24 references
MedicineOncologyPathologyCancer ImmunologyImmunopathologyTumor ImmunologyCytokine BiologyCytokine-mediated PathologyCytokines In Tumor ImmunityInflammatory SignalingTumor AntigensTumor ImmunopathologyCytokine Signaling In CancerCytokine Signaling In TumorsImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingPeritoneal MesotheliomaTumor-associated Cytokines
BACKGROUND: A high prevalence of thrombocytosis in malignant mesothelioma has been reported, although its pathogenesis remains unknown. METHODS: The case of a patient with marked thrombocytosis in peritoneal malignant mesothelioma is reported. To investigate the cytokines responsible for thrombocytosis in this patient, enzyme-linked immunosorbent assay and immunohistochemical analysis were used. RESULTS: Tumor cells produced large amounts of interleukin-6 (IL-6) and small amounts of granulocyte macrophage colony stimulating factor (GM-CSF) and monocyte colony stimulating factor (M-CSF). Immunocytochemical staining of tumor cells showed strong positivity for IL-6. CONCLUSIONS: These results indicated that persistent secretion of IL-6 promoted thrombogenesis in this patient.
24
Interleukin-1 and interleukin-1 antagonism
CA Dinarello · Blood · 1991 · 2.3K citations · Full text
Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
Shizuo Akira, Toshio Hirano, Tetsuya Taga et al. · The FASEB Journal · 1990 · 1.3K citations
Medicine, Immunology, Pathology +13
Primary structure and functional expression of rat and human stem cell factor DNAs
Francis H. Martin, Sidney V. Suggs, Keith E. Langley et al. · Cell · 1990 · 760 citations
Interleukin-6 is a potent thrombopoietic factor in vivo in mice
Toshiyuki Ishibashi, Hideo Kimura, Yayoi Shikama et al. · Blood · 1989 · 422 citations · Full text